DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LEUKOTRIENE D4
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LEUKOTRIENE D4
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN [INJECTION], BIPHASIC
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN [INJECTION], BIPHASIC
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM PERTECHNETATE TC 99M
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
SODIUM PERTECHNETATE TC 99M
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
NaO4Tc
Molecular Weight:
185.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEQUALINIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DEQUALINIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
E7QC7V26B8
Molecule Type:
Small molecule
Molecular Formula:
C30H40N4+2
Molecular Weight:
456.68
AlogP:
6.17
PSA:
59.8
HBD:
2.0
HBA:
#RotB:
11.0
Source:
CRISANTASPASE
4
Enzyme
Unknown
Unknown
Unknown
Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asparagine hydrolytic enzyme
CRISANTASPASE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FRESH FROZEN PLASMA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FRESH FROZEN PLASMA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIMETHINDENE MALEATE
4
Small molecule
Approved
Unknown
Unknown
Arrhythmias, Cardiac
Unknown
DIMETHINDENE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6LL60J9E0O
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O4
Molecular Weight:
408.5
AlogP:
4.15
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TELMISARTAN; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
TELMISARTAN; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALGINATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALGINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODAMIDE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODAMIDE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
6X283535A3
Molecule Type:
Small molecule
Molecular Formula:
C19H28I3N3O9
Molecular Weight:
823.16
AlogP:
2.79
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIGO CARMINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INDIGO CARMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APATINIB
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
APATINIB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBUPROFEN; OXYCODONE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
IBUPROFEN; OXYCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATALUREN
4
Small molecule
Approved
Unknown
Unknown
Aniridia; Epilepsy; Hemophilia A; Hemophilia B; Cystic Fibrosis; Muscular Dystrophy, Duchenne
80S Ribosome modulator
ATALUREN
×
Maximum Phase:
4
First Approval:
None
UNII:
K16AME9I3V
Molecule Type:
Small molecule
Molecular Formula:
C15H9FN2O3
Molecular Weight:
284.25
AlogP:
3.24
PSA:
76.22
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM IODIDE I-123
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
SODIUM IODIDE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEICOPLANIN
4
Unknown
Approved
Unknown
Unknown
Cystic Fibrosis; Osteomyelitis; Infections; Skin Diseases; Bacterial Infections
Peptidoglycan disrupting agent
TEICOPLANIN
×
Maximum Phase:
4
First Approval:
None
UNII:
4U3D3YY81M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVACIZUMAB-BVZR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BEVACIZUMAB-BVZR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM POLYSTYRENE SULFONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CALCIUM POLYSTYRENE SULFONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
HUI2S00793
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APRICOT KERNEL OIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
APRICOT KERNEL OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOCOPHERSOLAN
4
Unknown
Approved
Unknown
Unknown
Malaria; Short Bowel Syndrome; Hypobetalipoproteinemias
Unknown
TOCOPHERSOLAN
×
Maximum Phase:
4
First Approval:
None
UNII:
O03S90U1F2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHTHALYLSULFATHIAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PHTHALYLSULFATHIAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
6875L5852V
Molecule Type:
Small molecule
Molecular Formula:
C17H13N3O5S2
Molecular Weight:
403.44
AlogP:
2.89
PSA:
125.46
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CORTICOTROPIN-ZINC HYDROXIDE
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
CORTICOTROPIN-ZINC HYDROXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBALTOUS CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COBALTOUS CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
EVS87XF13W
Molecule Type:
Small molecule
Molecular Formula:
Cl2Co
Molecular Weight:
129.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
CARDIAC; PERFUSION
Unknown
Unknown
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NONACOG ALFA
4
Protein
Approved
Unknown
Unknown
Hemophilia B
Unknown
NONACOG ALFA
×
Maximum Phase:
4
First Approval:
None
UNII:
382L14738L
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
287
288
289
290
291
292
293
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA